Among these mitogens, the synaptic protein neuroligin-3 (NLGN3) was identified as the primary candidate, and soluble NLGN3 was shown to be necessary and sufficient for the robust proliferation of high-grade glioma cells. The gene discussed is NLGN3; the disease is glioma.